Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

various pending legal proceedings; expectations regarding King's financial condition and liquidity as well as future cash flows and earnings; expectations regarding the ability to liquidate King's holdings of auction rate securities and the temporary nature of the unrealized losses recorded in connection with these securities. Forward-looking statements involve risks and uncertainties. For further information regarding these and other risks related to King's business, investors should consult King's most recent Annual Report on Form 10-K for the year ended December 31, 2007 and King's quarterly reports on Form 10-Q and other documents filed by King with the Securities and Exchange Commission ("SEC").

Alpharma's Forward-Looking Statement

The statements contained herein that are not historical facts are considered forward-looking statements. Such forward-looking statements are based on the beliefs of our management as well as assumptions made by and information currently available to them and involve certain risks and uncertainties and other factors that could cause actual results to differ materially from those in the forward-looking statements. Alpharma has no obligation to update such forward-looking statements. Information on other important potential risks and uncertainties not discussed herein may be found in Alpharma's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2007 and its Form 10-Q for the quarter ended September 30, 2008. All forward-looking statements are qualified by these cautionary statements and are made only as of the date they are made.

Important Additional Information about the Tender Offer

This press release is provided for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell Alpharma Class A Common Stock. The solicitation and offer to buy Alpharma's Class A Common St
'/>"/>

SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... (PRWEB) July 29, 2014 ... in Situ Hybridization, Digital pathology & Workflow, ... Lymphoma, Prostate Cancer, Non Small Cell Lung ... End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract ... (The Americas, Europe, BRIC, Japan & RoW) ...
(Date:7/28/2014)... A lush green lawn offers the perfect setting for ... summer heat, lack of rain, foot traffic, and insects can ... The Grounds Guys recommends these suggestions for nurturing your summer ... week and set the height on the lawn mower about ... from heat and allows roots to retain water and grow ...
(Date:7/28/2014)... MI (PRWEB) July 28, 2014 UHY ... introduces the latest edition of UHY International Business – ... by our members, on the most current business challenges ... the world. Issue 29 covers the following topics:, ... Which industry sectors will thrive over the next five ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Dawn ... including sales, finance, and music. This experience has ... the direction of psychology. Her professional counseling ( ... and court-ordered treatment for offenders in domestic violence. ... Dawning Phoenix, LLC, she enjoys counseling individuals and ...
(Date:7/28/2014)... A revised version of a surgical procedure to treat ... more than 90 percent of the time in patients ... the MGH Division of Plastic and Reconstructive Surgery report ... the non-endoscopic procedure all of whom had headaches ... symptom relief a year later. The team,s paper ...
Breaking Medicine News(10 mins):Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 2Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 3Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 4Health News:Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets 5Health News:Nurturing Lawns in the Summer Heat: The Grounds Guys® Offers Tips on Caring for Lawns This Summer 2Health News:Uhy International Business Issue 29 Now Available 2Health News:Uhy International Business Issue 29 Now Available 3Health News:Dawn M. Echols, M.S., LPC of Dawning Phoenix Speaks at Newly Formed Task Force 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2
... , RIDGEFIELD, Conn., Sept. 24 Few people ... understanding of what it feels like to live with diabetes every ... That,s about to change. In recognition of World Diabetes Day on ... is challenging people living with diabetes to visually reveal its impact ...
... , , , ... simple task, especially when your child has a chronic health condition ... Frost, has partnered with nonprofit family health organization, Allergy & Asthma ... launch Ti m e 2 Talk Asthma , ...
... (September 24, 2009) Leon Reijmers, PhD, assistant professor ... Boston, is one of 55 recipients of the National ... investigating the way memories are stored in the brain, ... storage. Groups of neurons that participate in long-term ...
... recession, survey finds , THURSDAY, Sept. 24 (HealthDay News) -- ... for many Americans, according to a new survey that found ... a variety of body aches. , An American Pain Foundation ... those who suffered acute back pain or other minor muscle ...
... , NEW YORK, Sept. 24 An Ohio woman, 40-year-old Carolyn ... she,s due to deliver the first week in October is not hers. Several ... to his biological parents. The name of the clinic is not being released ... The AFA is issuing the following statements regarding the matter: , , ...
... , , ROCHESTER, ... Mayo Clinic and Microsoft Corp.,s shared vision to help families take ... to Mayo Clinic Health Manager , a free ... health. People with conditions such as hypertension and high cholesterol will ...
Cached Medicine News:Health News:Video: Making Sense of Diabetes Video Contest Asks 'What Does Diabetes Taste, Smell or Sound Like to You?' 2Health News:Video: Making Sense of Diabetes Video Contest Asks 'What Does Diabetes Taste, Smell or Sound Like to You?' 3Health News:Video: Making Sense of Diabetes Video Contest Asks 'What Does Diabetes Taste, Smell or Sound Like to You?' 4Health News:Parenting Expert and Family Advocate Jo Frost and Allergy & Asthma Network Mothers of Asthmatics (AANMA) Launch Time 2 Talk Asthma 2Health News:Parenting Expert and Family Advocate Jo Frost and Allergy & Asthma Network Mothers of Asthmatics (AANMA) Launch Time 2 Talk Asthma 3Health News:Neuroscientist from Tufts School of Medicine named NIH New Innovator 2Health News:Bad Economy Really Hurts Some Folks 2Health News:The American Fertility Association Responds to Alleged Embryo Mix-Up Case in Ohio 2Health News:The American Fertility Association Responds to Alleged Embryo Mix-Up Case in Ohio 3Health News:Mayo Clinic Health Manager Now Includes Features for People Managing Hypertension and High Cholesterol 2Health News:Mayo Clinic Health Manager Now Includes Features for People Managing Hypertension and High Cholesterol 3
(Date:7/28/2014)... 28, 2014 Concord Medical Services Holdings Limited ... ), a leading specialty hospital management solution provider and ... imaging centers in China , today ... Directors declared a special cash dividend of US$0.30 per ... on the Company,s outstanding ordinary shares. The total expense ...
(Date:7/28/2014)... CHAPEL HILL, N.C. , July 28, 2014 /PRNewswire/ ... results of a clinical trial demonstrating that CXL-1427, a ... was well tolerated in healthy volunteers. The company has ... failure in a Phase IIa clinical trial designed to ... as its dosing levels. The Phase I ...
(Date:7/28/2014)... CARLSBAD, Calif. , July 28, 2014  Isis ... following webcast:What:Isis Pharmaceuticals, Second Quarter 2014 Financial Results and ... / 7:30 a.m. PTWhere: www.isispharm.com How:Live on the ... you are unable to participate during the live event, ... a limited time at www.isispharm.com . ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... PRINCETON, N.J., May 27 Impliant, Inc., a ... today announced,that it has received FDA approval to ... its TOPS(TM) System, a Total Posterior Arthroplasty,device designed ... arthrosis,and spondylolisthesis., (Logo: http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ), ...
... Only Treatment for Hunter Syndrome Now Approved in 40 Countries ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May 27, Shire ... that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for the treatment ...
Cached Medicine Technology:Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System 2Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: